Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 73

1.

The immune contexture in human tumours: impact on clinical outcome.

Fridman WH, Pagès F, Sautès-Fridman C, Galon J.

Nat Rev Cancer. 2012 Mar 15;12(4):298-306. doi: 10.1038/nrc3245.

PMID:
22419253
[PubMed - indexed for MEDLINE]
2.

The role of cytokines in the epithelial cancer microenvironment.

Wilson J, Balkwill F.

Semin Cancer Biol. 2002 Apr;12(2):113-20. Review.

PMID:
12027583
[PubMed - indexed for MEDLINE]
3.

Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?

Shurin MR, Shurin GV, Lokshin A, Yurkovetsky ZR, Gutkin DW, Chatta G, Zhong H, Han B, Ferris RL.

Cancer Metastasis Rev. 2006 Sep;25(3):333-56. Review.

PMID:
17029028
[PubMed - indexed for MEDLINE]
4.

Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.

Berghuis D, Santos SJ, Baelde HJ, Taminiau AH, Egeler RM, Schilham MW, Hogendoorn PC, Lankester AC.

J Pathol. 2011 Feb;223(3):347-57. doi: 10.1002/path.2819. Epub 2010 Dec 10.

PMID:
21171080
[PubMed - indexed for MEDLINE]
5.

The immune contexture of primary and metastatic human tumours.

Giraldo NA, Becht E, Remark R, Damotte D, Sautès-Fridman C, Fridman WH.

Curr Opin Immunol. 2014 Apr;27:8-15. doi: 10.1016/j.coi.2014.01.001. Epub 2014 Feb 1. Review.

PMID:
24487185
[PubMed - indexed for MEDLINE]
6.

The tumor microenvironment and its contribution to tumor evolution toward metastasis.

Lorusso G, Rüegg C.

Histochem Cell Biol. 2008 Dec;130(6):1091-103. doi: 10.1007/s00418-008-0530-8. Epub 2008 Nov 6. Review.

PMID:
18987874
[PubMed - indexed for MEDLINE]
7.

The pros and cons of chemokines in tumor immunology.

Viola A, Sarukhan A, Bronte V, Molon B.

Trends Immunol. 2012 Oct;33(10):496-504. doi: 10.1016/j.it.2012.05.007. Epub 2012 Jun 20. Review.

PMID:
22726608
[PubMed - indexed for MEDLINE]
8.

Role of macrophages in tumour progression.

Siveen KS, Kuttan G.

Immunol Lett. 2009 Apr 27;123(2):97-102. doi: 10.1016/j.imlet.2009.02.011. Epub 2009 Mar 9. Review.

PMID:
19428556
[PubMed - indexed for MEDLINE]
9.

Tumour-immune cell interactions modulated by chemokines.

Jöhrer K, Pleyer L, Olivier A, Maizner E, Zelle-Rieser C, Greil R.

Expert Opin Biol Ther. 2008 Mar;8(3):269-90. doi: 10.1517/14712598.8.3.269 . Review.

PMID:
18294099
[PubMed - indexed for MEDLINE]
10.

Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells.

Bianchi G, Borgonovo G, Pistoia V, Raffaghello L.

Histol Histopathol. 2011 Jul;26(7):941-51. Review.

PMID:
21630223
[PubMed - indexed for MEDLINE]
11.

Cytokine regulation networks in the cancer microenvironment.

Sheu BC, Chang WC, Cheng CY, Lin HH, Chang DY, Huang SC.

Front Biosci. 2008 May 1;13:6255-68. Review.

PMID:
18508658
[PubMed - indexed for MEDLINE]
12.

Study of T lymphocytes infiltrating peritoneal metastases in advanced ovarian cancer: associations with vascular endothelial growth factor levels and prognosis in patients receiving platinum-based chemotherapy.

Tsiatas ML, Gyftaki R, Liacos C, Politi E, Rodolakis A, Dimopoulos MA, Bamias A.

Int J Gynecol Cancer. 2009 Nov;19(8):1329-34. doi: 10.1111/IGC.0b013e3181b7a40e.

PMID:
20009885
[PubMed - indexed for MEDLINE]
13.

Tumor immunosurveillance in human cancers.

Mlecnik B, Bindea G, Pagès F, Galon J.

Cancer Metastasis Rev. 2011 Mar;30(1):5-12. doi: 10.1007/s10555-011-9270-7. Review.

PMID:
21249426
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures.

Galon J, Angell HK, Bedognetti D, Marincola FM.

Immunity. 2013 Jul 25;39(1):11-26. doi: 10.1016/j.immuni.2013.07.008. Review.

PMID:
23890060
[PubMed - indexed for MEDLINE]
Free Article
15.

The prognostic impact of anti-cancer immune response: a novel classification of cancer patients.

Bindea G, Mlecnik B, Fridman WH, Galon J.

Semin Immunopathol. 2011 Jul;33(4):335-40. doi: 10.1007/s00281-011-0264-x. Epub 2011 Apr 5. Review.

PMID:
21461991
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

IL-23 promotes tumour incidence and growth.

Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, Smith K, Basham B, McClanahan T, Kastelein RA, Oft M.

Nature. 2006 Jul 27;442(7101):461-5. Epub 2006 May 10.

PMID:
16688182
[PubMed - indexed for MEDLINE]
17.

Chemokines in tumor-associated angiogenesis.

Gerber PA, Hippe A, Buhren BA, Müller A, Homey B.

Biol Chem. 2009 Dec;390(12):1213-23. doi: 10.1515/BC.2009.144. Review.

PMID:
19804363
[PubMed - indexed for MEDLINE]
18.

Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy.

Sato T, Terai M, Tamura Y, Alexeev V, Mastrangelo MJ, Selvan SR.

Immunol Res. 2011 Dec;51(2-3):170-82. doi: 10.1007/s12026-011-8262-6. Review.

PMID:
22139852
[PubMed - indexed for MEDLINE]
19.

Immune predictors of cancer progression.

Toh B, Chew V, Dai X, Khoo K, Tham M, Wai LE, Hubert S, Velumani S, Zhi L, Huang C, Abastado JP.

Immunol Res. 2012 Sep;53(1-3):229-34. doi: 10.1007/s12026-012-8288-4. Review.

PMID:
22407576
[PubMed - indexed for MEDLINE]
20.

The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer.

Bremnes RM, Al-Shibli K, Donnem T, Sirera R, Al-Saad S, Andersen S, Stenvold H, Camps C, Busund LT.

J Thorac Oncol. 2011 Apr;6(4):824-33. doi: 10.1097/JTO.0b013e3182037b76. Review.

PMID:
21173711
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk